Publications en collaboration avec des chercheurs de Instituto de Investigación del Hospital de La Princesa (17)

2024

  1. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565

  2. Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología

    Neurologia

  3. Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry

    British Journal of Dermatology, Vol. 190, Núm. 3, pp. 355-363

  4. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology, Vol. 59, Núm. 7, pp. 586-597

  5. Unravelling Migraine Stigma: A Comprehensive Review of Its Impact and Strategies for Change

    Journal of Clinical Medicine, Vol. 13, Núm. 17

  6. Use of Exposure Data to Establish Causality in Drug–Adverse Event Relationships: An Example with Desvenlafaxine

    Pharmaceuticals, Vol. 17, Núm. 1

2023

  1. Consensus about monoclonal antibodies in migraine of the Headache Study Group of the Madrid Association of Neurology

    Kranion, Vol. 18, Núm. 1, pp. 5-20

  2. Corrigendum to “Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry” [Digestive and Liver Disease Volume 55, Issue 3, March 2023, Pages 350–359] (Digestive and Liver Disease (2023) 55(3) (350–359), (S1590865822007289), (10.1016/j.dld.2022.09.020))

    Digestive and Liver Disease

  3. Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry

    Digestive and Liver Disease, Vol. 55, Núm. 3, pp. 350-359

  4. Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety

    Pharmaceutics, Vol. 15, Núm. 2

  5. Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine

    Frontiers in Pharmacology, Vol. 14

  6. Management of eosinophil-associated inflammatory diseases: the importance of a multidisciplinary approach

    Frontiers in Immunology, Vol. 14

2022

  1. Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam

    Biomedicine and Pharmacotherapy, Vol. 155

  2. Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 4, pp. 401-406

  3. Patients’ Perceived Satisfaction Through Telephone-Assisted Tele-Consultation During the SARS-CoV-2 Pandemic Period: Observational Single-Centre Study at a Tertiary-Referral Colorectal Surgery Department

    Surgical Innovation, Vol. 29, Núm. 1, pp. 35-43

  4. Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline

    Pharmaceutics, Vol. 14, Núm. 10

2017

  1. Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update

    Cancer Medicine, Vol. 6, Núm. 11, pp. 2606-2624